CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Feasibility of Oxaliplatin, Leucovorin, and 5-Fluorouracil (FOLFOX-4) Chemotherapy in Heavily Pretreated Patients with Recurrent Epithelial Ovarian Cancer

Hee Jun Lee, Hee Seung Kim, Noh Hyun Park, Hyun Hoon Chung, Jae Weon Kim, Yong Sang Song

Cancer Research and Treatment. 2013;45(1):40-47. Published online 2013 March 31 DOI: https://doi.org/10.4143/crt.2013.45.1.40

Feasibility of Oxaliplatin, Leucovorin, and 5-Fluorouracil (FOLFOX-4) Chemotherapy in Heavily Pretreated Patients with Recurrent Epithelial Ovarian Cancer

Hee Jun Lee, Hee Seung Kim, Noh Hyun Park, Hyun Hoon Chung, Jae Weon Kim, Yong Sang Song

Cancer Research and Treatment. 2013;45(1):40-47

Link1

Link2

Oxaliplatin Plus High-Dose Leucovorin and 5-Fluorouracil (FOLFOX 4) in Platinum-Resistant and Taxane-Pretreated Ovarian Cancer: A Phase II Study

J.T. Thigpen

Yearbook of Oncology. 2006;2006:128

Link1 Link2

Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer

Vincenza Conteduca, Giorgia Gurioli, Lorena Rossi, Emanuela Scarpi, Cristian Lolli, Giuseppe Schepisi, Alberto Farolfi, Delia De Lisi, Valentina Gallà, Salvatore Luca Burgio, Cecilia Menna, Andrea Amadori, Lorena Losi, Dino Amadori, Maria Paola Costi, Ugo De Giorgi

BMC Cancer. 2018;18(1):

Link1

Link2 Link3

Oxaliplatin, fluorouracil and leucovorin (FOLFOX) as first-line chemotherapy for metastatic or recurrent colorectal cancer patients

Bing Han, Ruihua Xu, Yanxia Shi, Huiyan Luo, Xiaojuan Xiang, Yuhong Li, Li Zhang, Tongyu Lin, Youjian He

Chinese Journal of Clinical Oncology. 2007;4(6):397-400

Link1

Link2 Link3

Oxaliplatin plus high-dose leucovorin and 5-fluorouracil (FOLFOX 4) in platinum-resistant and taxane-pretreated ovarian cancer: A phase II study

Dimitrios Pectasides, Melina Pectasides, Dimitrios Farmakis, Asimina Gaglia, Anna Koumarianou, Maria Nikolaou, Maria Koumpou, Panteleimon Kountourakis, Georgios Papaxoinis, Panagiota Mitrou, Theofanis Economopoulos, Sotirios A. Raptis

Gynecologic Oncology. 2004;95(1):165-172

Link1 Link2

PCN66 ECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE TREATMENT OF ADVANCED COLON-RECTUM CANCER IN CHINA

W Chen

Value in Health. 2010;13(7):A263

Link1 Link2

PCN22 ECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE TREATMENT OF ADVANCED GASTRIC CANCER IN CHINA

W Chen

Value in Health. 2010;13(7):A514

Link1 Link2

All-trans-retinoic acid (ATRA) plus oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX) versus FOLFOX alone as palliative chemotherapy in patients with advanced hepatocellular carcinoma and extrahepatic metastasis: study protocol for a randomized controlled trial

Jie Shi, Juxian Sun, Chang Liu, Zongtao Chai, Nanya Wang, Hui Zhang, Shuqun Cheng

Trials. 2019;20(1):

Link1

Link2 Link3

Cost-Effectiveness Analysis of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) versus FOLFOX-4 in Patients with RAS Wild-Type Metastatic Colorectal Cancer

Liangliang Bai, Pengfei Zhang, Kexun Zhou, Weiting Liao, Qiu Li

Cancer Management and Research. 2019;Volume 11:10419-10426

Link1 Link2

Phase II study of oxaliplatin plus leucovorin and 5-fluorouracil in heavily pretreated metastatic breast cancer patients

Si Sun, Lei Ping Wang, Jian Zhang, Xiao Yan Yang, Qun Ling Zhang, Zhen Jia, Xi Chun Hu, Bi Yun Wang

Medical Oncology. 2011;29(2):418-424

Link1

Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.